EE05691B1 - Ekspressioonivektorid ja nende rakendused - Google Patents
Ekspressioonivektorid ja nende rakendusedInfo
- Publication number
- EE05691B1 EE05691B1 EEP200300483A EEP200300483A EE05691B1 EE 05691 B1 EE05691 B1 EE 05691B1 EE P200300483 A EEP200300483 A EE P200300483A EE P200300483 A EEP200300483 A EE P200300483A EE 05691 B1 EE05691 B1 EE 05691B1
- Authority
- EE
- Estonia
- Prior art keywords
- vectors
- relates
- dna sequence
- nuclear
- binding
- Prior art date
Links
- 239000013604 expression vector Substances 0.000 title 1
- 239000013598 vector Substances 0.000 abstract 8
- 108090000623 proteins and genes Proteins 0.000 abstract 6
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 4
- 238000004873 anchoring Methods 0.000 abstract 3
- 230000027455 binding Effects 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108010041986 DNA Vaccines Proteins 0.000 abstract 2
- 229940021995 DNA vaccine Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000010076 replication Effects 0.000 abstract 2
- 230000004568 DNA-binding Effects 0.000 abstract 1
- 241000388186 Deltapapillomavirus 4 Species 0.000 abstract 1
- 108010008655 Epstein-Barr Virus Nuclear Antigens Proteins 0.000 abstract 1
- 101710125507 Integrase/recombinase Proteins 0.000 abstract 1
- 241001631646 Papillomaviridae Species 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20010922A FI116851B (fi) | 2001-05-03 | 2001-05-03 | Ilmentämisvektori, sen käyttöjä ja menetelmä sen valmistamiseksi sekä sitä sisältäviä tuotteita |
| PCT/FI2002/000379 WO2002090558A1 (en) | 2001-05-03 | 2002-05-03 | Novel expression vectors and uses thereof |
| US10/138,098 US7498314B2 (en) | 2001-05-03 | 2002-05-03 | Expression vectors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE200300483A EE200300483A (et) | 2004-04-15 |
| EE05691B1 true EE05691B1 (et) | 2013-12-16 |
Family
ID=26161168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200300483A EE05691B1 (et) | 2001-05-03 | 2002-05-03 | Ekspressioonivektorid ja nende rakendused |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1390516B1 (pt) |
| JP (1) | JP5016779B2 (pt) |
| CN (1) | CN100430482C (pt) |
| AP (1) | AP2368A (pt) |
| AT (1) | ATE426035T1 (pt) |
| AU (1) | AU2002253198B2 (pt) |
| BR (1) | BRPI0209416A8 (pt) |
| CA (1) | CA2446260C (pt) |
| CZ (1) | CZ301691B6 (pt) |
| DE (1) | DE60231613D1 (pt) |
| DK (1) | DK1390516T3 (pt) |
| EA (1) | EA009388B1 (pt) |
| EE (1) | EE05691B1 (pt) |
| ES (1) | ES2324095T3 (pt) |
| HK (1) | HK1063486A1 (pt) |
| HU (1) | HU227667B1 (pt) |
| IL (2) | IL158730A0 (pt) |
| MX (1) | MXPA03009978A (pt) |
| NZ (1) | NZ529327A (pt) |
| PL (1) | PL206097B1 (pt) |
| SI (1) | SI1390516T1 (pt) |
| SK (1) | SK287471B6 (pt) |
| WO (1) | WO2002090558A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004057005A1 (en) * | 2002-12-20 | 2004-07-08 | Fit Biotech Oyj Plc | Vectors lacking an origin of replication functioning in mammalian cells and expressing growth factors |
| FI116068B (fi) * | 2003-09-15 | 2005-09-15 | Fit Biotech Oyj Plc | Uusi selektiojärjestelmä, siinä käyttökelpoinen vektori, bakteerisolukantoja sekä menetelmä solujen valikoimiseksi |
| US8445431B2 (en) * | 2004-06-01 | 2013-05-21 | The Ohio State University | Ligands having metal binding ability and targeting properties |
| EP2047861B1 (en) * | 2007-10-12 | 2019-07-31 | Institut Pasteur | Lentiviral gene transfer vectors suitable for iterative administration and their medicinal applications |
| PT2185192T (pt) | 2007-08-03 | 2019-02-12 | Pasteur Institut | Vetores de transferência de genes lentivirais e suas aplicações medicinais |
| BRPI1010283B8 (pt) * | 2009-03-27 | 2021-05-25 | Eidgenoessische Technische Hochschule Zuerich | salmonella enterica apresentando n-glicano de c.jejuni ou derivados do mesmo, seu uso, método de produção e composição farmacêutica, alimento ou ração, aditivo alimentar ou de ração compreendendo a mesma |
| NZ708836A (en) | 2012-12-06 | 2020-07-31 | Pin Pharma Inc | Treatment of inflammation, autoimmune, and neurodegenerative disorders with immunosuppressive tat derivative polypeptides |
| CN107344962B (zh) * | 2016-05-04 | 2021-03-02 | 中国科学院微生物研究所 | 阻遏蛋白、调控元件组和基因表达调控系统及其构建方法 |
| WO2018185110A1 (en) | 2017-04-03 | 2018-10-11 | Fit Biotech Oy | Novel expression vectors and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
| WO1998007876A2 (en) * | 1996-08-16 | 1998-02-26 | Medical Research Council | Self-replicating episomal expression vectors conferring tissue-specific gene expression |
-
2002
- 2002-05-03 SI SI200230827T patent/SI1390516T1/sl unknown
- 2002-05-03 AP APAP/P/2003/002914A patent/AP2368A/en active
- 2002-05-03 PL PL367126A patent/PL206097B1/pl unknown
- 2002-05-03 EE EEP200300483A patent/EE05691B1/xx unknown
- 2002-05-03 AT AT02722308T patent/ATE426035T1/de active
- 2002-05-03 BR BRPI0209416A patent/BRPI0209416A8/pt not_active IP Right Cessation
- 2002-05-03 AU AU2002253198A patent/AU2002253198B2/en not_active Ceased
- 2002-05-03 IL IL15873002A patent/IL158730A0/xx unknown
- 2002-05-03 EA EA200301207A patent/EA009388B1/ru not_active IP Right Cessation
- 2002-05-03 ES ES02722308T patent/ES2324095T3/es not_active Expired - Lifetime
- 2002-05-03 CA CA2446260A patent/CA2446260C/en not_active Expired - Lifetime
- 2002-05-03 DK DK02722308T patent/DK1390516T3/da active
- 2002-05-03 DE DE60231613T patent/DE60231613D1/de not_active Expired - Lifetime
- 2002-05-03 NZ NZ529327A patent/NZ529327A/en not_active IP Right Cessation
- 2002-05-03 HU HU0304053A patent/HU227667B1/hu not_active IP Right Cessation
- 2002-05-03 EP EP02722308A patent/EP1390516B1/en not_active Expired - Lifetime
- 2002-05-03 CN CNB028133048A patent/CN100430482C/zh not_active Expired - Fee Related
- 2002-05-03 SK SK1469-2003A patent/SK287471B6/sk not_active IP Right Cessation
- 2002-05-03 CZ CZ20033201A patent/CZ301691B6/cs not_active IP Right Cessation
- 2002-05-03 JP JP2002587618A patent/JP5016779B2/ja not_active Expired - Fee Related
- 2002-05-03 MX MXPA03009978A patent/MXPA03009978A/es active IP Right Grant
- 2002-05-03 WO PCT/FI2002/000379 patent/WO2002090558A1/en active Application Filing
-
2003
- 2003-11-03 IL IL158730A patent/IL158730A/en active IP Right Grant
-
2004
- 2004-08-19 HK HK04106222.3A patent/HK1063486A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1114047T1 (el) | Νεοι φορεις εκφρασης και χρησεις αυτων | |
| ATE500323T1 (de) | Subtilisin-variante | |
| DK3184545T3 (da) | Antagonistiske selektive bindingsmidler af osteoprotegerin-bindingsprotein | |
| DK0953046T3 (da) | Human hæmatopoietisk stam- og progenitorcelleantigen og fremgangsmåder til anvendelse af dette | |
| CR10181A (es) | Anticuerpos anti-il-23 humanos, composiciones, metodos y usos | |
| BRPI0606790A2 (pt) | anticorpo humano isolado ou porção de ligação de antìgeno do mesmo, polipeptìdeo isolado, composição, ácido nucleico isolado, vetor de expressão célula hospedeira, vacina contra a raiva, kit, uso de um anticorpo monoclonal humano isolado ou porção de ligação de antìgeno do mesmo, ou de uma quantidade eficaz de uma composição, método para identificar um anticorpo ou um fragmento do mesmo, anticorpo ou fragmento do mesmo, anticorpo ou fragmento do mesmo,e, glicoproteìna. | |
| BR9813416A (pt) | Composições e métodos de nodavìrus recombinante | |
| DE60232895D1 (de) | Verwendung von agonistischen 4-1bb antikörpern zur erhöhung der immunantwort | |
| DE69926764D1 (de) | Methoden zur bestimmung von komponenten zur modulation des körpergewichts | |
| EE05691B1 (et) | Ekspressioonivektorid ja nende rakendused | |
| CY1107431T1 (el) | Σωματιδια για γoνιδιακη θεραπεια | |
| DK1309860T3 (da) | Fremgangsmåde til screening af peptider til anvendelse i immunterapi | |
| WO1999047558A3 (en) | T cell costimulatory proteins, sequences and uses thereof | |
| ATE384263T1 (de) | Verfahren zur bestimmung von biologischen agenzien in lebenden zielzellen | |
| WO2001057219A3 (en) | Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods | |
| DE60123819D1 (de) | Methode zur in vivo identifizierung von intrazellularen epitopen | |
| BR0115646A (pt) | Composição, dispositivo de liberação de partìculas, uso de uma composição, e, método para intensificar uma resposta imune contra um antìgeno de interesse em um paciente | |
| DK0781344T3 (da) | Hidtil ukendt implantat og hidtil ukendt vektor til behandling af erhvervede sygdomme | |
| ATE433489T1 (de) | 16836, ein mitglied der humanen phospholipase c familie und seine verwendungen | |
| ATE358727T1 (de) | Rekombinante bifunktionale fusionsproteine zur abtreibung variabler viren | |
| DK1328621T3 (da) | 13245, en ny human proteinkinase af den myotoniske dystrofitype og anvendelser deraf | |
| DE60136832D1 (de) | Atcr-1, eine humane acyltransferase und verwendungen davon | |
| DE60234047D1 (de) | 15603, ein mitglied der humanen ionenkanal-familie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC1A | Change of owner name |